Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,071,313
  • Shares Outstanding, K 94,814
  • Annual Sales, $ 16,140 K
  • Annual Income, $ -54,450 K
  • 60-Month Beta 1.68
  • Price/Sales 31.58
  • Price/Cash Flow N/A
  • Price/Book 16.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.14
  • Number of Estimates 5
  • High Estimate 0.21
  • Low Estimate 0.06
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +216.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.06 +41.26%
on 10/14/19
45.85 -1.24%
on 11/12/19
+12.73 (+39.11%)
since 10/11/19
3-Month
25.97 +74.36%
on 09/30/19
45.85 -1.24%
on 11/12/19
+16.02 (+54.75%)
since 08/12/19
52-Week
10.41 +334.97%
on 12/24/18
45.85 -1.24%
on 11/12/19
+32.45 (+252.92%)
since 11/12/18

Most Recent Stories

More News
SmarTrend Watching for Potential Pullback in Shares of Arrowhead Pharma After 35.23% Gain

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $42.90 to a high of $44.74. Yesterday, the shares gained 35.2%, which took the trading range above the 3-day high...

ARWR : 45.28 (+5.45%)
Arrowhead Pharma Up 39.9% Since SmarTrend Uptrend Call (ARWR)

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on October 4th, 2019 at $30.12. In approximately 1 month, Arrowhead Pharma has returned 39.95% as of today's recent price of $42.15.

ARWR : 45.28 (+5.45%)
Arrowhead Pharmaceuticals to Webcast Fiscal 2019 Year End Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on November 25, 2019, at 4:30 p.m. EST to discuss its financial results for the fiscal year...

ARWR : 45.28 (+5.45%)
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?

Style Box ETF report for FNY

FNY : 46.02 (+0.11%)
COUP : 133.04 (+0.13%)
IWP : 146.00 (+0.30%)
ARWR : 45.28 (+5.45%)
IJK : 228.88 (-0.20%)
ROKU : 135.35 (+4.75%)
Look for Shares of Arrowhead Pharma to Potentially Pullback after Yesterday's 23.88% Rise

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $39.32 to a high of $41.10. Yesterday, the shares gained 23.9%, which took the trading range above the 3-day high...

ARWR : 45.28 (+5.45%)
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting(R) 2019

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced Phase 2 clinical data on a double combination of JNJ-3989 (formerly ARO-HBV) and a nucleos(t)ide analog (NA), and the first clinical data on...

JNJ : 131.35 (-0.48%)
ARWR : 45.28 (+5.45%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 117.77 (+0.47%)
XLV : 95.31 (+0.60%)
VHT : 177.60 (+0.52%)
MDCO : 53.39 (-3.58%)
LHCG : 128.47 (+0.97%)
ARWR : 45.28 (+5.45%)
Arrowhead Pharma Up 29.0% Since SmarTrend Uptrend Call (ARWR)

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on October 4th, 2019 at $30.12. In approximately 1 month, Arrowhead Pharma has returned 29.04% as of today's recent price of $38.86.

ARWR : 45.28 (+5.45%)
Ironwood Pharmac is Among the Companies in the Biotechnology Industry with the Best Relative Performance (IRWD , AMGN , GILD , CELG , ARWR)

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AMGN : 221.31 (+0.28%)
GILD : 64.32 (-0.50%)
IRWD : 11.35 (+2.16%)
ARWR : 45.28 (+5.45%)
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO-ENaC at the North American Cystic Fibrosis Conference

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented preclinical data at the 2019 North American Cystic Fibrosis Conference (NACFC) on ARO-ENaC, an inhaled RNAi therapeutic being developed as...

ARWR : 45.28 (+5.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ARWR with:

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

2nd Resistance Point 47.63
1st Resistance Point 46.45
Last Price 45.28
1st Support Level 43.50
2nd Support Level 41.73

See More

52-Week High 45.85
Last Price 45.28
Fibonacci 61.8% 32.31
Fibonacci 50% 28.13
Fibonacci 38.2% 23.95
52-Week Low 10.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar